Multiple Sclerosis Clinical Trials

Testing BMS-986368 against a placebo for multiple sclerosis spasticity

Explore this study →

Sites in Edmonton, Lévis and 4 more cities

Official title: A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Multiple Sclerosis Spasticity · Celgene

Comparing THC with CBD for multiple sclerosis

Explore this study →

2 sites in Calgary

Official title: Cannabis (THC vs. CBD) in Multiple Sclerosis

Multiple Sclerosis · University of Calgary

Comparing Integrated Dual-task EMG Biofeedback with Traditional Balance Exercise Training for multiple sclerosis

Explore this study →

One site, in Hamilton

Official title: EMG Biofeedback Training to Improve Balance in Individuals with Multiple Sclerosis

Multiple Sclerosis · McMaster University

Testing Repetitive Transcranial Magnetic against a placebo for multiple sclerosis

Explore this study →

One site, in Gatineau

Official title: Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis

Multiple Sclerosis · Clinique Neuro-Outaouais

Testing Balance training with FES against a placebo for multiple sclerosis

Explore this study →

One site, in Toronto

Official title: Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis

Multiple Sclerosis · University Health Network, Toronto

Comparing 3 approaches for multiple sclerosis (MS)

Explore this study →

One site, in Toronto

Official title: A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Multiple Sclerosis (MS) · The Hospital for Sick Children

Comparing 4 approaches for multiple sclerosis

Explore this study →

One site, in Montreal

Official title: A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

Multiple Sclerosis · Hoffmann-La Roche

Comparing 4 approaches for relapsing multiple sclerosis

Explore this study →

Sites in Edmonton, Lévis and 2 more cities

Official title: Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Relapsing Multiple Sclerosis · Novartis Pharmaceuticals

Comparing AZD0120 - Regimen 1 with AZD0120 - Regimen 2 for multiple sclerosis

Explore this study →

One site, in Montreal

Official title: An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Multiple Sclerosis · AstraZeneca

Testing Remibrutinib (blinded) with Remibrutinib (Open label) against a placebo for secondary progressive multiple sclerosis (SPMS)

Explore this study →

Sites in Montreal, Halifax and 5 more cities

Official title: A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS) · Novartis Pharmaceuticals

Testing ETNATM-ProgMS for relapsing remitting multiple sclerosis (RRMS)

Explore this study →

Sites in Montreal, Calgary and 8 more cities

Official title: ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Relapsing Remitting Multiple Sclerosis (RRMS) · Novartis Pharmaceuticals

Cannabis as a Complementary Treatment in Multiple Sclerosis

Explore this study →

One site, in Montreal

Multiple Sclerosis · Centre hospitalier de l'Université de Montréal (CHUM)